DTYMK and cancer: Higher expression of DTYMK was correlated with shorter RFS in cancers including ACC (p = 0.00068), BLCA (p = 0.045), KIRP (p = 0.0069), LGG (p = 1.6e-05), LIHC (p = 0.011), LUAD (p = 0.0045), PAAD (p = 0.0086), PRAD (p = 0.0066), SKCM (p = 0.02), and UVM (p = 0.02) (Figures 10J–S).